Cardiovascular disease in haemodialysis: role of the intravascular innate immune system

Kristina N. Ekdahl,Inga Soveri,Jöns Hilborn,Bengt Fellström,Bo Nilsson
DOI: https://doi.org/10.1038/nrneph.2017.17
IF: 42.439
2017-02-27
Nature Reviews Nephrology
Abstract:Key PointsHaemodialysis is a life-saving renal replacement modality for end-stage renal disease, but this therapy is associated with an increased risk of cardiovascular diseaseThe biomaterial surfaces that come into contact with blood in the extracorporeal circuit during haemodialysis trigger activation of the intravascular cascade systemsGeneration of activation products from the intravascular cascade systems causes systemic inflammation involving blood cells and the vascular treeThe anaphylatoxins C3a and C5a, bradykinin, thrombin and factor Xa can induce activation of endothelial cells and the vascular wallThe thrombotic and inflammatory properties of these activation products lead to atherogenesis, which can progress to arteriosclerosis and cardiovascular disease
urology & nephrology
What problem does this paper attempt to address?